<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" > <channel><title>Comments on: Ketek: &quot;A time bomb&quot;</title> <atom:link href="http://www.kevinmd.com/blog/2006/12/ketek-time-bomb.html/feed" rel="self" type="application/rss+xml" /><link>http://www.kevinmd.com/blog/2006/12/ketek-time-bomb.html</link> <description></description> <lastBuildDate>Tue, 14 Feb 2012 11:46:00 +0000</lastBuildDate> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /> <item><title>By: Rich, MD</title><link>http://www.kevinmd.com/blog/2006/12/ketek-time-bomb.html#comment-69622</link> <dc:creator>Rich, MD</dc:creator> <pubDate>Fri, 15 Dec 2006 17:23:00 +0000</pubDate> <guid isPermaLink="false">http://clients.emmense.com/kevinmd/2006/12/ketek-a-time-bomb.html#comment-69622</guid> <description>John,&lt;br/&gt;&lt;br/&gt;From the PI:&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Special senses:&lt;/b&gt; &lt;i&gt;Visual adverse events most often included blurred vision, diplopia, or difficulty focusing. Most events were mild to moderate; however, severe cases have been reported. Some patients discontinued therapy due to these adverse events. Visual adverse events were reported as having occurred after any dose during treatment, but most visual adverse events (65%) occurred following the first or second dose. Visual events lasted several hours and recurred upon subsequent dosing in some patients. For patients who continued treatment, some resolved on therapy while others continued to have symptoms until they completed the full course of treatment.&lt;/i&gt;</description> <content:encoded><![CDATA[<p>John,</p><p>From the PI:</p><p><b>Special senses:</b> <i>Visual adverse events most often included blurred vision, diplopia, or difficulty focusing. Most events were mild to moderate; however, severe cases have been reported. Some patients discontinued therapy due to these adverse events. Visual adverse events were reported as having occurred after any dose during treatment, but most visual adverse events (65%) occurred following the first or second dose. Visual events lasted several hours and recurred upon subsequent dosing in some patients. For patients who continued treatment, some resolved on therapy while others continued to have symptoms until they completed the full course of treatment.</i></p> ]]></content:encoded> </item> <item><title>By: John J. Coupal</title><link>http://www.kevinmd.com/blog/2006/12/ketek-time-bomb.html#comment-69621</link> <dc:creator>John J. Coupal</dc:creator> <pubDate>Fri, 15 Dec 2006 16:12:00 +0000</pubDate> <guid isPermaLink="false">http://clients.emmense.com/kevinmd/2006/12/ketek-a-time-bomb.html#comment-69621</guid> <description>Rich,&lt;br/&gt;  Are you sure that the accomodation problems were due to Ketek and not from the disease process itself?</description> <content:encoded><![CDATA[<p>Rich,<br /> Are you sure that the accomodation problems were due to Ketek and not from the disease process itself?</p> ]]></content:encoded> </item> <item><title>By: Rich, MD</title><link>http://www.kevinmd.com/blog/2006/12/ketek-time-bomb.html#comment-69620</link> <dc:creator>Rich, MD</dc:creator> <pubDate>Fri, 15 Dec 2006 13:40:00 +0000</pubDate> <guid isPermaLink="false">http://clients.emmense.com/kevinmd/2006/12/ketek-a-time-bomb.html#comment-69620</guid> <description>I agree with Kevin. There are many alternatives, and no good reason to use this medication. &lt;br/&gt;&lt;br/&gt;Not to mention the fairly high incidence of visual accommodation problems - when this drug was first released, my office took several calls, i.e. &quot;I started the antibiotics, and now I can&#039;t see!&quot;</description> <content:encoded><![CDATA[<p>I agree with Kevin. There are many alternatives, and no good reason to use this medication.</p><p>Not to mention the fairly high incidence of visual accommodation problems &#8211; when this drug was first released, my office took several calls, i.e. &#8220;I started the antibiotics, and now I can&#8217;t see!&#8221;</p> ]]></content:encoded> </item> <item><title>By: John J. Coupal</title><link>http://www.kevinmd.com/blog/2006/12/ketek-time-bomb.html#comment-69603</link> <dc:creator>John J. Coupal</dc:creator> <pubDate>Thu, 14 Dec 2006 23:02:00 +0000</pubDate> <guid isPermaLink="false">http://clients.emmense.com/kevinmd/2006/12/ketek-a-time-bomb.html#comment-69603</guid> <description>I took Ketek for a sinus infection. Great stuff!</description> <content:encoded><![CDATA[<p>I took Ketek for a sinus infection. Great stuff!</p> ]]></content:encoded> </item> </channel> </rss>
<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using apc
Page Caching using disk: enhanced
Database Caching 2/6 queries in 0.003 seconds using memcached
Object Caching 374/378 objects using apc
Content Delivery Network via cdn.kevinmd.com

Served from: www.kevinmd.com @ 2012-02-14 09:39:23 -->
